These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 26603425

  • 1. Anti-cancer and cardioprotective effects of indol-3-carbinol in doxorubicin-treated mice.
    Adwas AA, Elkhoely AA, Kabel AM, Abdel-Rahman MN, Eissa AA.
    J Infect Chemother; 2016 Jan; 22(1):36-43. PubMed ID: 26603425
    [Abstract] [Full Text] [Related]

  • 2. Prevention of doxorubicin (DOX)-induced genotoxicity and cardiotoxicity: Effect of plant derived small molecule indole-3-carbinol (I3C) on oxidative stress and inflammation.
    Hajra S, Patra AR, Basu A, Bhattacharya S.
    Biomed Pharmacother; 2018 May; 101():228-243. PubMed ID: 29494960
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Indole-3-Carbinol (I3C) enhances the sensitivity of murine breast adenocarcinoma cells to doxorubicin (DOX) through inhibition of NF-κβ, blocking angiogenesis and regulation of mitochondrial apoptotic pathway.
    Hajra S, Patra AR, Basu A, Saha P, Bhattacharya S.
    Chem Biol Interact; 2018 Jun 25; 290():19-36. PubMed ID: 29775573
    [Abstract] [Full Text] [Related]

  • 5. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY, Najjar TA, Alashari M.
    J Biochem Mol Toxicol; 2004 Jun 25; 18(2):78-86. PubMed ID: 15122649
    [Abstract] [Full Text] [Related]

  • 6. Protective effects of mito-TEMPO against doxorubicin cardiotoxicity in mice.
    Rocha VC, França LS, de Araújo CF, Ng AM, de Andrade CM, Andrade AC, Santos Ede S, Borges-Silva Mda C, Macambira SG, Noronha-Dutra AA, Pontes-de-Carvalho LC.
    Cancer Chemother Pharmacol; 2016 Mar 25; 77(3):659-62. PubMed ID: 26712129
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. (-)-Epigallocatechin-3-gallate alleviates doxorubicin-induced cardiotoxicity in sarcoma 180 tumor-bearing mice.
    Yao YF, Liu X, Li WJ, Shi ZW, Yan YX, Wang LF, Chen M, Xie MY.
    Life Sci; 2017 Jul 01; 180():151-159. PubMed ID: 27956351
    [Abstract] [Full Text] [Related]

  • 9. Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity.
    al-Shabanah OA, Badary OA, Nagi MN, al-Gharably NM, al-Rikabi AC, al-Bekairi AM.
    J Exp Clin Cancer Res; 1998 Jun 01; 17(2):193-8. PubMed ID: 9700580
    [Abstract] [Full Text] [Related]

  • 10. Cardioprotective effects of minocycline against doxorubicin-induced cardiotoxicity.
    Naderi Y, Khosraviani S, Nasiri S, Hajiaghaei F, Aali E, Jamialahmadi T, Banach M, Sahebkar A.
    Biomed Pharmacother; 2023 Feb 01; 158():114055. PubMed ID: 36495663
    [Abstract] [Full Text] [Related]

  • 11. Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats.
    Aziz MM, Abd El Fattah MA, Ahmed KA, Sayed HM.
    Can J Physiol Pharmacol; 2020 Apr 01; 98(4):183-193. PubMed ID: 31665614
    [Abstract] [Full Text] [Related]

  • 12. The Effects of Mangiferin (Mangifera indica L) in Doxorubicin-induced Cardiotoxicity in Rats.
    Arozal W, Suyatna FD, Juniantito V, Rosdiana DS, Amurugam S, Aulia R, Monayo ER, Siswandi R.
    Drug Res (Stuttg); 2015 Nov 01; 65(11):574-80. PubMed ID: 25426848
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nanoceria ameliorates doxorubicin induced cardiotoxicity: Possible mitigation via reduction of oxidative stress and inflammation.
    Sangomla S, Saifi MA, Khurana A, Godugu C.
    J Trace Elem Med Biol; 2018 May 01; 47():53-62. PubMed ID: 29544808
    [Abstract] [Full Text] [Related]

  • 15. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
    Jagetia GC, Reddy TK, Malagi KJ, Nayak BS, Naidu MB, Ravikiran PB, Kamath SU, Shetty PC, Reddy DS.
    Phytother Res; 2005 Sep 01; 19(9):772-8. PubMed ID: 16220569
    [Abstract] [Full Text] [Related]

  • 16. Ameliorative effect of naringin against doxorubicin-induced acute cardiac toxicity in rats.
    Kwatra M, Kumar V, Jangra A, Mishra M, Ahmed S, Ghosh P, Vohora D, Khanam R.
    Pharm Biol; 2016 Sep 01; 54(4):637-47. PubMed ID: 26471226
    [Abstract] [Full Text] [Related]

  • 17. [Effects of indole-3-carbinol on the outcome of tumor and the changes of anti-oxidative system in null mice grafted with nasopharyngeal carcinoma].
    Zhu W, Yang GY, Zhang QX, Li JT, Li WX.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Oct 01; 43(10):885-9. PubMed ID: 20137469
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt/GSK-3β signaling pathway.
    Abbas NAT, Kabil SL.
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Nov 01; 390(11):1145-1153. PubMed ID: 28780599
    [Abstract] [Full Text] [Related]

  • 20. Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats.
    Ammar el-SM, Said SA, Suddek GM, El-Damarawy SL.
    Can J Physiol Pharmacol; 2011 Apr 01; 89(4):269-76. PubMed ID: 21526973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.